Browse studies

Find your next paid study

1 recruiting study matching your filters

A Randomized, Placebo-Controlled, Single Ascending Dose (SAD) Study to Assess the Safety, Tolerability, and Pharmacokinetics of SER-252 in Patients With Parkinson's Disease and Motor Fluctuations

This is a randomized, placebo-controlled, single ascending dose (SAD) study of SER-252 in participants with Parkinson's Disease (PD) and motor fluctuations.

PARKINSON DISEASE (Disorder)Advanced Parkinson's Disease

Serina TherapeuticsNCT07422675